Explore What We Do
Access the latest company announcements, financial reports and shareholder information. Explore key resources and stay up to date with our business and performance.

Our vision
Mission: Enhance personal health through scientific tools and solutions
Core Business: Development and manufacture of analytical and life sciences products and devices.
Focus: Improving human well-being through consumable products, devices, and solutions for analysing biological, food, water, and environmental samples.
Vision: Drive decentralised, personalised, data-based healthcare through our product portfolio and technology pipeline.
Company Structure
Headquarters: Australia
Global Presence: Operations in Australia, Europe, the US, and Asia.
Manufacturing: Seven dedicated precision manufacturing facilities in Australia, Europe, Malaysia, and the US.
Team: Over 600 employees worldwide.

Our Businesses

Analytical Products
Trajan’s analytical products and components are sold to a broad range of participants in the analytical science industry, including large OEMs, pharmaceutical, food and CRO laboratories and scientific distribution companies.
Life Sciences Solutions
Trajan's life sciences solutions focus on areas directly related to human health. We enhance and optimise workflows with a variety of automated preparative or sample collection systems ready to integrate into laboratories, or generate custom solutions for life science research and development.
Corporate history
Trajan was established in 2011 by Stephen and Angela Tomisich with the aim of enriching human well-being through scientific measurement. Stephen and Angela have extensive backgrounds in analytical chemistry and biomedical science and together have over 50 years’ experience in global analytical science and clinical trial management.
Trajan's operations were initiated by the acquisition of two pathology consumables businesses in 2011 and 2013.
In 2013, Trajan made the significant acquisition of the chromatography and liquid handling businesses of SGE Analytical Science, which was a participant in the highly specialised analytical syringe sector, as well as having a range of other chromatography products.
In 2015, Trajan made the strategic decision to focus on everything that touches the sample in the analytical workflow, investing significantly in the modernisation of its manufacturing processes and relocating its US and European operations into modern, custom-fitted facilities, as it did later with the acquisition of workflow automation provider LEAP Technologies in 2016.





